| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +53.7K | 12.3% | $8.58 | +$461K |
| Sells | 6 | -382K | 87.7% | $13.94 | -$5.33M |
| Net | -4 | -329K | -75.4% | -$4.87M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alexander J. Denner | Director, More than 10% owner | $144M | Mar 15, 2024 | ||
| Thomas A. MCCOURT | Chief Executive Officer, Director | $10.6M | -$3.35M | -24% | Mar 8, 2024 |
| Mark G. Currie | Director | $6.09M | Jun 20, 2023 | ||
| Jason Rickard | SVP, Chief Operating Officer | $4.21M | Mar 8, 2023 | ||
| Michael Shetzline | CMO,SVP,Head-Res&Drug | $3.74M | -$693K | -15.6% | Mar 8, 2024 |
| Edward P. Owens | Director | $3.15M | Jun 2, 2021 | ||
| Sravan Kumar Emany | SVP, Chief Financial Officer | $2.95M | +$400K | +15.7% | Mar 8, 2024 |
| Minardo John | Chief Legal Officer | $2.71M | -$793K | -22.6% | Mar 8, 2024 |
| Andrew Davis | SVP, Chief Business Officer | $2.7M | -$246K | -8.33% | Mar 8, 2024 |
| Ronald Silver | Principal Accounting Officer | $2.46M | -$140K | -5.4% | Feb 12, 2024 |
| Andrew Dreyfus | Director | $1.89M | Jun 20, 2023 | ||
| Julie McHugh | Director | $1.82M | Jun 20, 2023 | ||
| Catherine Moukheibir | Director | $1.44M | Dec 15, 2023 | ||
| Jay Shepard | Director | $1.14M | Jun 20, 2023 | ||
| Marla L. Kessler | Director | $1.08M | -$111K | -9.32% | Dec 14, 2023 |
| Jon R. Duane | Director | $1.05M | +$60.2K | +6.06% | Mar 6, 2024 |
| Lawrence S. Olanoff | Director | $1.02M | Jun 2, 2021 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|